Metaplanet
3350
Mitsubishi Heavy Industries
7011
Nippon Telegraph & Telephone
9432
4
Sanrio
8136
5
Kioxia Holdings
285A
JP Stock MarketDetailed Quotes
4591 Ribomic
- 109
- +7+6.86%
20min DelayMarket Closed Feb 18 15:30 JST
4.55BMarket Cap-3.80P/E (Static)
110High103Low2.07MVolume103Open102Pre Close221.44MTurnover12352wk High5.33%Turnover Ratio41.73MShares6052wk Low-25.7EPS TTM4.23BFloat Cap2078Historical HighLossP/E (Static)38.78MShs Float60Historical Low-28.7EPS LYR6.86%Amplitude--Dividend TTM1.35P/B100Lot Size--Div YieldTTM
About Ribomic Company
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
Company Profile
Symbol4591
Company NameRibomic
Founded2003-08-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-16-13 Usui Building Shirokanedai, Minato-ku
Zip Code108-0071
Phone03-3440-3303
Websitewww.ribomic.com
Company Executives
- Name
- Position
- Salary
- Takeo Adachi
- Director and Executive Officer, Head of Research and Development Division and Head of Discovery Research Department
- --
- Hisato Ooiwa
- Director and Executive Officer, Head of Administration Division
- --
- Yoshikazu Nakamura
- Representative Director, President and Head of Business Promotion Headquarters
- --
- Toshiaki Nishihata
- Independent Director
- --
- Matsufuji Chiya
- Independent Director
- --
- Toshinobu Fujiwara
- Independent Director
- --